Genetic Subgroups Inform On Pathobiology In Adult And Pediatric Burkitt Lymphoma

Blood. Epub, October 6, 2022 10.1182/blood.2022016534

Burkitt lymphoma (BL) accounts for the majority of pediatric non-Hodgkin lymphomas being less common but significantly more lethal when diagnosed in adults. Much of our knowledge of the genetics of BL thus far has originated from the study of pediatric BL (pBL), leaving its relationship to adult (aBL) and other adult lymphomas not fully explored. We sought to more thoroughly identify the somatic changes that underlie lymphomagenesis in aBL and any molecular features that associate with clinical disparities within and between pBL and aBL.

Through comprehensive whole-genome sequencing of 230 BL and 252 diffuse large B-cell lymphoma (DLBCL) tumors, we identified additional significantly mutated genes (SMGs) including more genetic features that associate with tumor EBV status, and unraveled new distinct subgroupings within BL and DLBCL with three predominantly comprising BLs: DGG-BL (DDX3X, GNA13 and GNAI2), IC-BL (ID3, CCND3), and M53-BL (MYC, TP53). Each BL subgroup is characterized by combinations of common driver and non-coding mutations caused by aberrant somatic hypermutation (aSHM). The largest subgroups of BL cases, IC-BL and DGG-BL are further characterized by distinct biological and gene expression differences.

IC-BL and DGG-BL and their prototypical genetic features (ID3 and TP53) had significant associations with patient outcomes that were different among aBL and pBL cohorts. These findings highlight shared pathogenesis between aBL and pBL, and establish genetic subtypes within BL that serve to delineate tumors with distinct molecular features, providing a new framework for epidemiological, diagnostic, and therapeutic strategies.

Keywords: Burkitt Lymphoma, mRNA-Seq, miRNA-Seq, WGS, FFPE

Supplemental Data

• GDC Manifests
  • CGCI-BLGSP Controlled-Access Data Download Manifest (3 Files)
  • CGCI-BLGSP Open-Access Data Download Manifest (8 Files)
  • CGCI-HTMCP-DLBCL Controlled-Access Data Download Manifest (2 Files)
  • CGCI-HTMCP-DLBCL Open-Access Data Download Manifest (4 Files)

• Clinical Data
  • Supplemental Clinical Data Update

• miRNA
  • CGCI-BLGSP miRNA-Seq Level 3 Data
  • CGCI-HTMCP-DLBCL miRNA-Seq Level 3 Data

• mRNA
  • CGCI-BLGSP mRNA-Seq Level 3 Data
  • CGCI-BLGSP mRNA-Seq Level 3 Data (Controlled)
  • CGCI-BLGSP mRNA-Seq Metadata
  • CGCI-HTMCP-DLBCL mRNA-Seq Level 3 Data
  • CGCI-HTMCP-DLBCL mRNA-Seq Level 3 Data (Controlled)

• Targeted Capture Sequencing
  • CGCI-BLGSP Targeted Capture Sequencing Level 3 Data (Controlled)
  • CGCI-BLGSP Targeted Capture Sequencing Design
  • CGCI-BLGSP Targeted Capture Sequencing Metadata

• Whole Genome Sequencing
  • CGCI-BLGSP WGS Level 2 Data
  • CGCI-BLGSP WGS Level 3 Data (Controlled)
  • CGCI-BLGSP WGS Metadata
  • CGCI-HTMCP-DLBCL WGS Level 3 Data
  • CGCI-HTMCP-DLBCL WGS Level 3 Data (Controlled)

• Miscellaneous Files
  • CGCI-BLGSP Sample Matrix
  • CGCI-HTMCP-DLBCL Sample Matrix

Additional Resources

• Office of Cancer Genomics (link is external)

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT ( Download, User's Guide)
   • GDC API ( User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal ( Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT ( Download, User’s Guide)
   • GDC API ( User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.